Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HN.4.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.4.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HN.4.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.4.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HN.4.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDD.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDD.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDD.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDD.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDD.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDD.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.16.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.16.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.5.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HW.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
HW.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HW.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
HW.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HW.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HW.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HW.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HW.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.27EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used